Veradermics raises target price to $204 from $170
MANE•B. Riley raised its target price for Veradermics to $204 from $170.
Related News
BridgeBio to report third-quarter 2026 financial results
BBIO•
Danaher target price raised to $250 from $240 by Leerink Partners
DHR•
Edible Garden enters produce supply agreement with Caney Fork Farms
EDBL•
Gibraltar Industries publishes update to financial calendar
ROCK•
Verastem announces third-quarter results conference call
VSTM•